Live Breaking News & Updates on Retinal Laser Probes

Stay updated with breaking news from Retinal laser probes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Iridex Reports First Quarter 2023 Financial Results

MOUNTAIN VIEW, Calif., May 11, 2023 Iridex Corporation , a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today reported. | May 11, 2023 ....

United States , Philip Taylor , David Bruce , Exchange Commission , Iridex Corporation Nasdaq , Iridex Corporation , Gilmartin Group , Laser Systems , Sweep Management , Full Year , Conference Call , Securities Act , Annual Report , Consolidated Statements , Iridex Corporation Stock Exchange , Press Release , Oday Irix Us4626841013 ,

C. Light Technologies: C. Light Receives Clearance for Retinal Eye Movement Monitor, Retitrack

Revolutionary medical device is first retinal eye-movement monitor for non-invasive, objective clinical assessmentsBOSTON, MA / ACCESSWIRE / May 11, 2023 / C. Light Technologies, Inc., a venture-funded ....

United States , Joe Xing , James Wang , Berkeley Skydeck , Christy Sheehy Bensinger , Link To Press Kit , National Institute Of Health , National Timmy Award For Best Tech Startup , Drug Administration , Alzheimer Drug Discovery Foundation , C Light Technologies Inc , Press Kit , Flight Technologies , Yamaha Motor Ventures , National Institute , Drug Discovery , Timmy Award , Tech Startup , North America , Business Achievement , Most Innovative Woman , Alight Media , Gefallene Big Techs ,

FDA Accepts SBLA For Genentech's Vabysmo For Retinal Vein Occlusion Treatment

SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, a member of the Roche Group (RHHBY), said that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application ....

More Such Health News , Roche Group , Drug Administration , Biologics License Application , Gefallene Big Techs ,

F. Hoffmann-La Roche Ltd: FDA accepts application for Roche's Vabysmo for the treatment of retinal vein occlusion (RVO)

Acceptance based on two phase III studies that demonstrated early and sustained vision improvement with Vabysmo, meeting primary endpoint of non-inferiority compared to afliberceptApplication was further ....

United Kingdom , United States , Birgit Masjost , Nathalie Altermatt , Sabine Borngr , Levi Garraway , Sileia Urech , Kirti Pandey , Karsten Kleine , Polypoidal Choroidal Vasculopathy , Loren Kalm , Bruno Eschli , Gerard Tobin , European Union , Roche Group Media Relations , Roche Group , Regulatory Agency , Drug Administration , Chugai Pharmaceutical Co , European Medicines Agency , Head Of Global Product Development , European Society , Biologics License Application , Chief Medical Officer , Global Product , Port Delivery System ,

Glaukos Announces First Quarter 2023 Financial Results

Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced. | May 3, 2023 ....

Thomas Burns , International Glaucoma , Ivantis Inc , Corneal Health , Glaukos Corporation , Avedro Inc , Exchange Commission , Investor Relations , Quarterly Summary , Micro Invasive Glaucoma Surgery , Annual Report , Quarterly Report , Investor Section , Regarding Use , Generally Accepted Accounting Principles , Glaukos Corporation Stock Exchange , Press Release , Oday Gkos Us3773221029 ,